High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies
Highlights •A new probe, PM-PBB3, captures pathological tau deposits in vivo with high contrast •PM-PBB3 allows an individual-based identification of AD and non-AD tauopathies •Autopsy assays of PET-scanned